Paper38332005
The scientific journey of a novel adjuvant (AS37) from bench to bedside.
D'Oro U and 1 other. NPJ Vaccines, 2024. Cited by 13 papers, by iCite.
Cite this record
ConductScience Library. The scientific journey of a novel adjuvant (AS37) from bench to bedside. Papers, record 38332005. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38332005
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References68
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 29801750 | Correlates of adjuvanticity: A review on adjuvants in licensed vaccines. | Semin Immunol | 2018 | https://conductscience.org/library/papers/29801750 | PubMed |
| 2 | 33257234 | The continued advance of vaccine adjuvants - 'we can work it out'. | Semin Immunol | 2020 | https://conductscience.org/library/papers/33257234 | PubMed |
| 3 | 28855902 | Different Adjuvants Induce Common Innate Pathways That Are Associated with Enhanced Adaptive Responses against a Model Antigen in Humans. | Front Immunol | 2017 | https://conductscience.org/library/papers/28855902 | PubMed |
| 4 | 30850240 | Inflammatory parameters associated with systemic reactogenicity following vaccination with adjuvanted hepatitis B vaccines in humans. | Vaccine | 2019 | https://conductscience.org/library/papers/30850240 | PubMed |
| 5 | 33177181 | Transcriptional profiles of adjuvanted hepatitis B vaccines display variable interindividual homogeneity but a shared core signature. | Sci Transl Med | 2020 | https://conductscience.org/library/papers/33177181 | PubMed |
| 6 | 27236001 | Impact of adjuvants on CD4(+) T cell and B cell responses to a protein antigen vaccine: Results from a phase II, randomized, multicenter trial. | Clin Immunol | 2016 | https://conductscience.org/library/papers/27236001 | PubMed |
| 7 | 34021167 | Antibody avidity, persistence, and response to antigen recall: comparison of vaccine adjuvants. | NPJ Vaccines | 2021 | https://conductscience.org/library/papers/34021167 | PubMed |
| 8 | 36890168 | Systems serology-based comparison of antibody effector functions induced by adjuvanted vaccines to guide vaccine design. | NPJ Vaccines | 2023 | https://conductscience.org/library/papers/36890168 | PubMed |
| 9 | 36258023 | Development of a TLR7/8 agonist adjuvant formulation to overcome early life hyporesponsiveness to DTaP vaccination. | Sci Rep | 2022 | https://conductscience.org/library/papers/36258023 | PubMed |
| 10 | 32845153 | Modulation of the Innate Immune Response by Targeting Toll-like Receptors: A Perspective on Their Agonists and Antagonists. | J Med Chem | 2020 | https://conductscience.org/library/papers/32845153 | PubMed |
| 11 | 26344622 | Immune Adjuvant Effect of Molecularly-defined Toll-Like Receptor Ligands. | Vaccines (Basel) | 2014 | https://conductscience.org/library/papers/26344622 | PubMed |
| 12 | 33824489 | Emerging concepts in the science of vaccine adjuvants. | Nat Rev Drug Discov | 2021 | https://conductscience.org/library/papers/33824489 | PubMed |
| 13 | 36177016 | A comprehensive review of BBV152 vaccine development, effectiveness, safety, challenges, and prospects. | Front Immunol | 2022 | https://conductscience.org/library/papers/36177016 | PubMed |
| 14 | 30566863 | Structural Analyses of Toll-like Receptor 7 Reveal Detailed RNA Sequence Specificity and Recognition Mechanism of Agonistic Ligands. | Cell Rep | 2018 | https://conductscience.org/library/papers/30566863 | PubMed |
| 15 | 26138638 | Bacterial RNA: An Underestimated Stimulus for Innate Immune Responses. | J Immunol | 2015 | https://conductscience.org/library/papers/26138638 | PubMed |
| 16 | 20004021 | A five-amino-acid motif in the undefined region of the TLR8 ectodomain is required for species-specific ligand recognition. | Mol Immunol | 2010 | https://conductscience.org/library/papers/20004021 | PubMed |
| 17 | 22587897 | Molecular evolution of vertebrate Toll-like receptors: evolutionary rate difference between their leucine-rich repeats and their TIR domains. | Gene | 2012 | https://conductscience.org/library/papers/22587897 | PubMed |
| 18 | 15233738 | Modulating vaccine responses with dendritic cells and Toll-like receptors. | Immunol Rev | 2004 | https://conductscience.org/library/papers/15233738 | PubMed |
| 19 | 31904601 | Toward precision adjuvants: optimizing science and safety. | Curr Opin Pediatr | 2020 | https://conductscience.org/library/papers/31904601 | PubMed |
| 20 | 24910635 | Dendritic cell-targeted vaccines. | Front Immunol | 2014 | https://conductscience.org/library/papers/24910635 | PubMed |
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42188770 | Lipid Nanoparticle-Encapsulated PolyI:C as an Adjuvant Enhances Both Humoral and Cellular Immune Responses to the Hepatitis B Vaccine. | Vaccines (Basel) | 2026 | https://conductscience.org/library/papers/42188770 | PubMed |
| 40918123 | Distinct effects of adjuvants on B cell responses to protein or polysaccharide antigens contained in glycoconjugate vaccines. | Front Immunol | 2025 | https://conductscience.org/library/papers/40918123 | PubMed |
| 40692104 | Scale-up and cGMP manufacturing of next-generation vaccine adjuvant saponin/MPLA nanoParticles (SMNP). | J Pharm Sci | 2025 | https://conductscience.org/library/papers/40692104 | PubMed |
| 40536024 | Advances in vaccine adjuvant development and future perspectives. | Drug Deliv | 2025 | https://conductscience.org/library/papers/40536024 | PubMed |
| 40421643 | Development of a Recombinant Outer Membrane Vesicles (OMVs)-Based Vaccine Against Helicobacter pylori Infection in Mice. | J Extracell Vesicles | 2025 | https://conductscience.org/library/papers/40421643 | PubMed |
| 40281311 | TLR7-Adjuvanted Ionizable Lipid Nanoparticles for mRNA Vaccine Delivery. | AAPS J | 2025 | https://conductscience.org/library/papers/40281311 | PubMed |
| 39951545 | Linking vaccine adjuvant mechanisms of action to function. | Sci Immunol | 2025 | https://conductscience.org/library/papers/39951545 | PubMed |
| 39772007 | Vaccine Strategies Against RNA Viruses: Current Advances and Future Directions. | Vaccines (Basel) | 2024 | https://conductscience.org/library/papers/39772007 | PubMed |
| 39204028 | Intranasal Delivery of Quillaja brasiliensis Saponin-Based Nanoadjuvants Improve Humoral Immune Response of Influenza Vaccine in Aged Mice. | Vaccines (Basel) | 2024 | https://conductscience.org/library/papers/39204028 | PubMed |
| 38932410 | Water-Soluble and Freezable Aluminum Salt Vaccine Adjuvant. | Vaccines (Basel) | 2024 | https://conductscience.org/library/papers/38932410 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| TLR7 | 51284 | PubTator's text mining | https://conductscience.org/library/genes/51284 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/38332005
GET https://conductscience.org/api/papers/v1/38332005/references?page=2